Tag Archives: Sharp Therapeutics Corp

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – August 29, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company“) announces the release of its condensed interim consolidated financial statements for the three and six months ended June 30, 2025, and related management discussion and analysis. All dollar …

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – January 27, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a pre-clinical stage biotechnology company specializing in small molecule drugs to treat genetic diseases, is pleased to announce the successful completion of its previously announced consolidation of its common shares (the “Common …